Toxicity of a particulate formulation for the intraperitoneal application of mitoxantrone

International Journal of Pharmaceutics

Volumn 180, Issue 2, 1999, Pages 251-260

  Luftensteiner, Christian P ^a   Schwendenwein, Ilse ^a   Eichler, Hans G ^a   Paul, Bettina ^a   Wölfl, Gabriele ^a   Viernstein, Helmut ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Albumin microspheres; Animal studies; Intraperitoneal chemotherapy; Mitoxantrone; Survival; Toxicity

Indexed keywords

ALBUMIN; MICROSPHERE; MITOXANTRONE;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BONE MARROW TOXICITY; CONTROLLED STUDY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; FLUID INTAKE; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TOXICITY TESTING; URINARY EXCRETION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; BODY WEIGHT; EATING; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MICROSPHERES; MITOXANTRONE; PARTICLE SIZE; PERITONITIS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SURVIVAL ANALYSIS; URINATION;

EID: 0032964244     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00011-3     Document Type: Article

References (23)

1. Alberts D.S., Surwit E.A., Peng Y.M., McCloskey T., Rivest R., Graham V., McDonald L., Roe D. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration. Cancer Res. 48:1988;5874-5877.
2. Blöchl-Daum B., Eichler H.G., Rainer H., Jakesz R., Salzer H., Steger G., Schüller J., Günther E., Proksch B., Ehninger G. Escalating dose regimen of intraperitoneal mitoxantrone: phase I study - clinical and pharmacokinetic evaluation. Eur. J. Cancer Clin. Oncol. 24:1988;1133-1138.
3. Chappell W.R., Mordenti J. Extrapolation of toxicological and pharmacological data from animals to humans. Testa B. Advances in Drug Research. 20:1991;1-116 Academic Press, London.
4. Demetrick J.S., Liggins R.T., Machan L., Davis N.L., Burt H.M., Hunter W.L. The development of a novel intraperitoneal tumor-seeding prophylactic. Am. J. Surg. 173:1997;403-406.
5. Diwan P.V., Margaret I., Ramakrishna S. Influence of gymnema sylvestre on inflammation. Inflammopharmacology. 3:1995;271-277.
6. Hagiwara A., Takahashi T., Kojima O., Sawai K., Yamaguchi T., Yamane T., Taniguchi H., Kitamura K., Noguchi A., Seiki K., Sakakura C. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet. 339:1992;629-631.
7. Hagiwara A., Takahashi T., Kojima O., Yamaguchi T., Sasabe T., Lee M., Sakakura C., Shoubayashi S., Ikada Y., Hyon S.H. Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents. Cancer. 71:1993;844-850.
8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1997. ICH Harmonised Tripartite Guideline, Impurities: Guideline for Residual Solvents, Step 4 (Final Draft), 17 July.
9. Jain N.C. Essentials of Veterinary Hematology. 1993;Lea and Febiger, Philadelphia, PA.
10. Jaksch W., Glawischnig E. Klinische Propädeutik der inneren Krankheiten und Hautkrankheiten der Haustiere. 2nd edn:1981;Parey, Berlin.
11. Kleinbaum D.G. Survival Analysis. 1996;Springer, Berlin.
12. Knüsli C., Ruff P., Laffer U., Stoll H.R., Obrist R., Weber W., Obrecht J.P. Intraperitoneal chemotherapy in peritoneal malignancy: impact of intensive system care on practicability. Acta Med. Austriaca. 16:1989;70-73.
13. Lee J.S., Takahashi T., Hagiwara A., Yoneyama C., Itoh M., Sasabe T., Muranishi S., Tashima S. Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis. Cancer Chemother. Pharmacol. 36:1995;211-216.
14. Lorusso V., Catino A., Gargano G., Fioretto A., Berardi F., De Lena M. Mitoxantrone in the treatment of recurrent ascites of pretreated ovarian carcinoma. Eur. J. Gynaec. Oncol. 15:1994;75-80.
15. Luftensteiner C.P., Viernstein H. Statistical experimental design based studies on placebo and mitoxantrone-loaded albumin microspheres. Int. J. Pharm. 171:1998;87-99.
16. Luftensteiner, C.P., Schwendenwein, I., Paul, B., Eichler, H.G., Viernstein, H., 1999. Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats, J. Control. Release, 57, 35-44.
17. Maiche A.G. Management of peritoneal effusions with intracavitary mitoxantrone or bleomycin. Anti-Cancer Drugs. 5:1994;305-308.
18. Markman M., Reichman B., Hakes T., Curtin J., Jones W., Lewis J.L. Jr., Barakat R., Rubin S., Mychalczak B., Saigo P., Almadrones L., Hoskins W. Intraperitoneal chemotherapy in the management of ovarian cancer. Cancer. 71:1993;1565-1570.
19. Sachs L. Angewandte Statistik. 7th edn:1992;Springer, Berlin.
20. Scheffé H. The Analysis of Variance. 1959;Wiley, New York.
21. US Pharmacopeia XXIII, 1995. US Pharmacopeial Convention, Rockville, MD, pp. 1746-1748.
22. Vonesh E.F., Chinchilli V.M. Linear and Nonlinear Models for the Analysis of Repeated Measurements. 1996;Dekker, New York.
23. Witowski J., Breborowicz A., Knapowski J. Effect of methotrexate, doxorubicin and mitoxantrone on human peritoneal mesothelial cell function in vitro. Oncology. 52:1995;60-65.